Charles Schwab’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Sell |
296,468
-3,266
| -1% | -$7.12K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $818K | Buy |
299,734
+7,754
| +3% | +$21.2K | ﹤0.01% | 2910 |
|
|
2024
Q4 | $1.21M | Sell |
291,980
-7,693
| -3% | -$32K | ﹤0.01% | 2841 |
|
|
2024
Q3 | $1.17M | Buy |
299,673
+761
| +0.3% | +$2.96K | ﹤0.01% | 2873 |
|
|
2024
Q2 | $1.17M | Buy |
298,912
+56,020
| +23% | +$220K | ﹤0.01% | 2869 |
|
|
2024
Q1 | $1.02M | Sell |
242,892
-851
| -0.3% | -$3.57K | ﹤0.01% | 2791 |
|
|
2023
Q4 | $1.15M | Buy |
243,743
+5,271
| +2% | +$24.8K | ﹤0.01% | 2787 |
|
|
2023
Q3 | $744K | Hold |
238,472
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q2 | $1.09M | Sell |
238,472
-189
| -0.1% | -$868 | ﹤0.01% | 2740 |
|
|
2023
Q1 | $1.18M | Buy |
238,661
+5,516
| +2% | +$27.3K | ﹤0.01% | 2684 |
|
|
2022
Q4 | $1.27M | Buy |
233,145
+3,176
| +1% | +$17.3K | ﹤0.01% | 2705 |
|
|
2022
Q3 | $1.5M | Buy |
229,969
+38,797
| +20% | +$252K | ﹤0.01% | 2666 |
|
|
2022
Q2 | $905K | Sell |
191,172
-31,697
| -14% | -$150K | ﹤0.01% | 2832 |
|
|
2022
Q1 | $1.56M | Buy |
222,869
+15,047
| +7% | +$105K | ﹤0.01% | 2726 |
|
|
2021
Q4 | $2.12M | Buy |
207,822
+173,485
| +505% | +$1.77M | ﹤0.01% | 2690 |
|
|
2021
Q3 | $420K | Buy |
+34,337
| New | +$420K | ﹤0.01% | 3195 |
|